Literature DB >> 18455906

Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma.

C Li1, S Kim, J F Lai, S J Oh, W J Hyung, W H Choi, S H Choi, Z G Zhu, S H Noh.   

Abstract

AIM: To evaluate the clinicopathological factors influencing lymph node metastasis around the splenic artery and hilum and the effect of spleen-preserved lymphadenectomy in advanced middle third gastric carcinoma.
METHODS: We retrospectively studied 131 patients with advanced middle third gastric carcinoma who had received D2 lymphadenectomy and lymph node dissection around the splenic artery and hilum, from 2000 to 2004. Of these patients, 62 simultaneously underwent splenectomy and 69 underwent spleen-preserved lymphadenectomy.
RESULTS: The incidences of Nos. 10 and 11 lymph node metastases were 21% and 15%, respectively, in advanced middle third gastric carcinoma. A tumor size larger than 5 cm, metastases of Nos. 1 and 7-9 lymph node were independent risk factors for metastasis of No. 10 and/or No. 11 lymph node. The spleen-preserved group had a slightly better survival rate and a relatively lower rate of postoperative complications than the splenectomy group. No. 10 and/or No. 11 lymph node metastasis was an independent prognostic factor, while splenectomy was not.
CONCLUSIONS: It is necessary to remove the lymph nodes around the splenic artery and hilum to achieve radical resection in advanced middle third gastric carcinoma patients with risk factors. Our results demonstrate that spleen-preserved lymphadenectomy is a good option for those patients.

Entities:  

Mesh:

Year:  2008        PMID: 18455906     DOI: 10.1016/j.ejso.2008.03.011

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  Laparoscopic versus open total gastrectomy with D2 dissection for gastric cancer: a meta-analysis.

Authors:  Weizhi Wang; Zheng Li; Jie Tang; Meilin Wang; Baolin Wang; Zekuan Xu
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-30       Impact factor: 4.553

2.  Robot-assisted laparoscopic gastrectomy with D2 dissection for adenocarcinoma: initial experience with 17 patients.

Authors:  R Pugliese; D Maggioni; F Sansonna; G C Ferrari; S Di Lernia; C Magistro; I Pauna; A Forgione; A Costanzi; C Brambilla; F Pugliese
Journal:  J Robot Surg       Date:  2008-11-26

3.  SAGES TAVAC safety and effectiveness analysis: da Vinci ® Surgical System (Intuitive Surgical, Sunnyvale, CA).

Authors:  Shawn Tsuda; Dmitry Oleynikov; Jon Gould; Dan Azagury; Bryan Sandler; Matthew Hutter; Sharona Ross; Eric Haas; Fred Brody; Richard Satava
Journal:  Surg Endosc       Date:  2015-07-24       Impact factor: 4.584

4.  Reappraise role of No. 10 lymphadenectomy for proximal gastric cancer in the era of minimal invasive surgery during total gastrectomy: a pooled analysis of 4 prospective trial.

Authors:  Qing Zhong; Qi-Yue Chen; Yan-Chang Xu; Gang Zhao; Li-Sheng Cai; Guo-Xin Li; Ze-Kuan Xu; Su Yan; Zu-Guang Wu; Fang-Qin Xue; Yi-Hong Sun; Dong-Po Xu; Wen-Bin Zhang; Jin Wan; Pei-Wu Yu; Jian-Kun Hu; Xiang-Qian Su; Jia-Fu Ji; Zi-Yu Li; Jun You; Yong Li; Lin Fan; Chao-Hui Zheng; Jian-Wei Xie; Ping Li; Chang-Ming Huang
Journal:  Gastric Cancer       Date:  2020-07-26       Impact factor: 7.370

5.  Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer.

Authors:  Kun Yang; Minah Cho; Chul Kyu Roh; Won Jun Seo; Seohee Choi; Taeil Son; Hyoung-Il Kim; Woo Jin Hyung
Journal:  Surg Endosc       Date:  2019-04-03       Impact factor: 4.584

Review 6.  A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer.

Authors:  Savtaj S Brar; Rajini Seevaratnam; Roberta Cardoso; Calvin Law; Lucy Helyer; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-09-14       Impact factor: 7.370

7.  Early results of a modified splenic hilar lymphadenectomy in laparoscopy-assisted total gastrectomy for gastric cancer with stage cT1-2: a case-control study.

Authors:  Guoxian Guan; Weizhong Jiang; Zhifen Chen; Xing Liu; Huishan Lu; Xiangfu Zhang
Journal:  Surg Endosc       Date:  2012-12-28       Impact factor: 4.584

8.  Clinicopathological features of patients with middle third gastric carcinoma.

Authors:  Jin Hong Kim; Jae Kyoon Joo; Seong Yeob Ryu; Ho Gun Kim; Jae Hyuk Lee; Dong Yi Kim
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

9.  Survival benefit and safety of no. 10 lymphadenectomy for gastric cancer patients with total gastrectomy.

Authors:  Kun Yang; Wei-Han Zhang; Xin-Zu Chen; Xiao-Long Chen; Bo Zhang; Zhi-Xin Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

10.  Comparisons Between Different Procedures of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy.

Authors:  Kun Yang; Zheng-Hao Lu; Wei-Han Zhang; Kai Liu; Xin-Zu Chen; Xiao-Long Chen; Dong-Jiao Guo; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.